Gallery
- PM Modi visit USAOnly the mirror in my washroom and phone gallery see the crazy me : Sara KhanKarnataka rain fury: Photos of flooded streets, uprooted treesCannes 2022: Deepika Padukone stuns at the French Riviera in Sabyasachi outfitRanbir Kapoor And Alia Bhatt's Wedding Pics - Sealed With A KissOscars 2022: Every Academy Award WinnerShane Warne (1969-2022): Australian cricket legend's life in picturesPhotos: What Russia's invasion of Ukraine looks like on the groundLata Mangeshkar (1929-2022): A pictorial tribute to the 'Nightingale of India'PM Modi unveils 216-feet tall Statue of Equality in Hyderabad (PHOTOS)
Hockey India on Monday announced the 20-member squad for the Men's Junior Asia Cup, a qual
- Harmanpreet Singh named FIH Player of the Year, PR Sreejesh gets best goalkeeper award
- World Boxing medallist Gaurav Bidhuri to flag off 'Delhi Against Drugs' movement on Nov 17
- U23 World Wrestling Championship: Chirag Chikkara wins gold as India end campaign with nine medals
- FIFA president Infantino confirms at least 9 African teams for the 2026 World Cup
- Hockey, cricket, wrestling, badminton, squash axed from 2026 CWG in Glasgow
How 'chimpanzee poop' is helping prevent COVID-19 Last Updated : 05 Apr 2021 06:06:14 PM IST The Oxford–AstraZeneca Covid-19 vaccine, a version of which is also being used in India, is made from an adenovirus isolated from chimpanzee poop, which has been genetically changed so that it is impossible for it to grow in humans.
Now known as Covid-19 Vaccine AstraZeneca, it was formerly called AZD1222.AZD1222 was co-invented by the University of Oxford and its spin-out company, Vaccitech. It uses a replication-deficient chimpanzee viral vector based on a weakened version of a common cold virus (adenovirus) that causes infections in chimpanzees and contains the genetic material of the SARS-CoV-2 virus spike protein.After vaccination, the surface spike protein is produced, priming the immune system to attack the SARS-CoV-2 virus if it later infects the body.The vaccine has been granted a conditional marketing authorisation or emergency use in more than 70 countries across six continents.The Serum Institute of India (SII), the world's largest vaccine manufacturer by volume, is manufacturing a version of the Oxford-AstraZeneca Covid-19 vaccine named 'Covishield' in India.India is stepping up vaccination efforts against Covid-19 amid a renewed surge in the number of cases. The country registered 1,03,558 new coronavirus cases in the last 24 hours, the highest ever single-day spike since the onset of the pandemic last year, taking the total tally to 1,25,89,067 on Monday.On Monday, the death toll increased to 1,65,101 with 478 new fatalities.The number of people who have recovered from the disease surged to 1,16,82,136, while the case fatality rate stood at 1.31 per cent, according to official data.So far, 7.91 crore doses of Corona vaccine have been administered in the country since the drive began on January 16 after the approval for Covishield and Bharat Biotech's Covaxin.The vaccination drive started for healthcare workers on January 16, followed by vaccination for frontline workers from February 2. Later, persons aged 60 years and above and those in the age group of 45-59 years with identified 20 comorbidities were covered from March 1.Subsequently, from April 1, all persons aged 45 years and above are eligible for Covid vaccination.IANS New Delhi For Latest Updates Please-
Join us on
Follow us on
172.31.16.186